U.S. FDA panel to review Emergent’s OTC opioid overdose drug
(Reuters) – The U.S. health regulator said on Tuesday its advisory panel will meet on Feb. 15 to review Emergent Biosolutions Inc’s over-the-counter (OTC) nasal spray to treat suspected opioid…